6743ef5282e80.pdf
DOI:
Mavjud emas
Kesik-Brodacka M. Progress in Biopharmaceutical Development. Biotechnol. Appl. Biochem. 2018;65:306–322. doi: 10.1002/bab.1617 Itragotri S., Burke PA, Langer R. Overcoming the Challenges in Administering Biopharmaceuticals: Formulation and Delivery Strategies. Nat. Rev. Drug Discov. 2014;13:655–672. doi: 10.1038/nrd4363. 3.Gosudarstvennaya pharmacopoeia Rossiyskoy Federasii, X I izd., Moscow (2018); [Electronic resource], URL : https :// femb . ru / record / pharmacopoeia 14 .4.Shodieva N.B., Yunusova H.M. Studies on studying the biopharmaceutical properties and stability of "STIGER-S" tablet// Pharmaceutical Bulletin of Uzbekistan. –2017. No. 2. B. 10-15.5.State Pharmacopoeia of the Republic of Uzbekistan. Tashkent. -2021. Volume 1, Part 1-2.6.Maksudova FX . Biopharmaceutical studies of combined capsules of nonsteroidal anti-inflammatory action// Farmasevticheskiy jurnal.-Tashkent. -2016.-No. 1. -S.88-91.7.Komilova MM, Karieva Yo.S., Mirzakamolova DS Setting the conditions for conducting the "Solubility" test for Efavirenz capsules // Pharmacy. –2024. #4. B.37-41